UB Paderborn / Katalog / Suche / in CDI

1 – 13 von 13

Sortiert nach

FLORA-5/GOG3035: Chemo-immunotherapy (paclitaxel-carboplatin-oregovomab [PCO] vs chemotherapy (paclitaxel-carboplatin-placebo [PCP]) as front-line treatment in patients with advanced epithelial ovarian cancer (EOC)—Phase III, double blind, placebo controlled, global, multinational study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS5625-TPS5625

2023

Link zum Volltext

Verfügbarkeit prüfen

Real-time Doppler ultrasound to identify vessels and guide needle placement for gynecologic interstitial brachytherapy

Brachytherapy, 2018-09, Vol.17 (5), p.742-746

2018

Link zum Volltext

Verfügbarkeit prüfen

TP011/#1536 A double-blind placebo-controlled phase III chemo-immunotherapy (Paclitaxel-carboplatin-oregovomab [PCO]) vs chemotherapy (Paclitaxel-carboplatin-placebo [PCP]) in patients with newly diagnosed, advanced epithelial ovarian cancer (EOC): FLORA-5/GOG-3035 study

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A250-A251

2023

Link zum Volltext

Verfügbarkeit prüfen

TP021/#1521 FLORA-5/GOG3035: chemo-immunotherapy (paclitaxel and carboplatin ± oregovomab) as front-line treatment for patients with ovarian cancer. A phase III double blind placebo controlled, global multicenter study

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A233-A234

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-Time Doppler Ultrasound to Identify Vessels and Guide Needle Placement for Gynecologic Interstitial Brachytherapy

Brachytherapy, 2018-07, Vol.17 (4), p.S114-S115

2018

Link zum Volltext

Verfügbarkeit prüfen

Effective Treatment of Stage I Uterine Papillary Serous Carcinoma with High Dose-Rate Vaginal Apex Radiation ( 192Ir) and Chemotherapy

International journal of radiation oncology, biology, physics, 1998, Vol.40 (1), p.77-84

1998

Link zum Volltext

Verfügbarkeit prüfen

Operative laparoscopy and the gynecologic oncologist. Commentary and review

Cancer, 1995-11, Vol.76 (S10), p.1987-1991

1995

Link zum Volltext

Verfügbarkeit prüfen

Ovarian hyperstimulation syndrome in the emergency department: A case report

The Journal of emergency medicine, 1994-07, Vol.12 (4), p.481-484

1994

Link zum Volltext

Verfügbarkeit prüfen

The role of laparoscopy in the management of gynecologic malignancy

Seminars in surgical oncology, 1994-11, Vol.10 (6), p.431-439

1994

Link zum Volltext

Verfügbarkeit prüfen

1 – 13 von 13

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(13)

Sprache

Englisch
(13)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(6)
Oncology
(6)
Science & Technology
(6)
Female
(5)
Humans
(5)
Biological And Medical Sciences
(3)
Chemotherapy
(3)
Medical Sciences
(3)
Adult
(2)
Aged
(2)
Brachytherapy
(2)
Double-Blind Studies
(2)
Genital Neoplasms, Female - Surgery
(2)
Gynecology. Andrology. Obstetrics
(2)
Middle Aged
(2)
Neoplasm Staging
(2)
Ovarian Cancer
(2)
Radiology, Nuclear Medicine & Medical Imaging
(2)
Aged, 80 And Over
(1)
Antigens
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis

Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu

FLORA-5/GOG3035: Chemo-immunotherapy (paclitaxel-carboplatin-oregovomab [PCO] vs chemotherapy (paclitaxel-carboplatin-placebo [PCP]) as front-line treatment in patients with advanced epithelial ovarian cancer (EOC)—Phase III, double blind, placebo controlled, global, multinational study

FLORA-5: A phase III double blind placebo controlled multicenter clinical study of front-line chemo-immunotherapy (paclitaxel and carboplatin +/- oregovomab) in patients with advanced epithelial ovarian cancer (GOG-3035) (298)

Real-time Doppler ultrasound to identify vessels and guide needle placement for gynecologic interstitial brachytherapy

TP011/#1536 A double-blind placebo-controlled phase III chemo-immunotherapy (Paclitaxel-carboplatin-oregovomab [PCO]) vs chemotherapy (Paclitaxel-carboplatin-placebo [PCP]) in patients with newly diagnosed, advanced epithelial ovarian cancer (EOC): FLORA-5/GOG-3035 study

Randomized phase II trial of carboplatin-paclitaxel compared to carboplatin-paclitaxel-trastuzumab in advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress Her2/Neu (NCT01367002): updated overall survival analysis

TP021/#1521 FLORA-5/GOG3035: chemo-immunotherapy (paclitaxel and carboplatin ± oregovomab) as front-line treatment for patients with ovarian cancer. A phase III double blind placebo controlled, global multicenter study

Real-Time Doppler Ultrasound to Identify Vessels and Guide Needle Placement for Gynecologic Interstitial Brachytherapy

Effective Treatment of Stage I Uterine Papillary Serous Carcinoma with High Dose-Rate Vaginal Apex Radiation ( 192Ir) and Chemotherapy

Operative laparoscopy and the gynecologic oncologist. Commentary and review

Ovarian hyperstimulation syndrome in the emergency department: A case report

The role of laparoscopy in the management of gynecologic malignancy

Suchergebnisse filtern